Dr Seerapani Gopaluni, Nephrologist

MBBS, MRCP, CCT

Nephrologist

Dr Seerapani Gopaluni Appointment and Practice Location

Citizens Specialty Hospitals, Nallagandla

1-100/1/CCH, Near Aparna Sarovar, Nallagandla,

Nallagandla, Hyderabad

Get Directions

OP Timings

Mon - Sat

11:00 am - 03:00 pm

Fee: 800

Practice Locations (1)
Profile
Patient Reviews
Q&A
Media

About Dr Seerapani Gopaluni Nephrologist

Dr. Seerapani Gopaluni is a highly respected and renowned Nephrologist with over 20 years of experience in Hyderabad. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dr. Y.S.R University of Health Sciences in Vijayawada, Andhra Pradesh. Dr. Seerapani received his Membership of the Royal Colleges of Physicians (MRCP) and earned the Certificate of Completion of Training (CCT) in Nephrology from the British Council in the United Kingdom. He also underwent Internal Medical Training at the prestigious Oxford University Clinical Academic Graduate School in the United Kingdom. Dr. Seerapani holds a Doctor of Philosophy (PhD) in Renal Medicine from the University of Cambridge in the United Kingdom.

Dr. Seerapani specializes in treating various kidney disorders, including chronic kidney disease and acute kidney failure management. He is an expert in renal health, dealing with Glomerulonephritis, Polycystic kidney disease, Kidney stones, and Nephrotic syndrome. Dr. Seerapani's specialization extends into expertise in renal transplantation and managing autoimmune conditions such as lupus and vasculitis.

He has received numerous notable accolades in Nephrology throughout Europe. Moreover, he has published over two dozen seminal research papers in renowned journals. You can book an appointment with Dr. Seerapani Gopaluni, who currently works as a Consultant Nephrologist at Citizens Specialty Hospitals - Nallagandla.

Specializations

Nephrologist/ Renal Specialist

Expertises

Nephrology

Qualifications

MBBS - Andhra Medical College - 2003 - Vishakapatnam
MRCP - Royal Colleges of Physicians - 2008 - London
MRCP - Nephrology - The Federation of Royal College of Physicians - 2013 - London
CCT - Nephrology - General Medical Council - 2014 - UK
CCT - General Internal Medicine - Oxford University - 2014 - UK
PhD - Autoimmune Diseases - University of Cambridge - 2021 - England

Experiences

Consultant Nephrologist Citizens Specialty Hospitals - Nallagandla - Currently Working

Registrations

49196 Telangana State Medical Council 2003

Awards and Recognitions

First Division in MBBS Final Examinations
Distinction in Ophthalmology University Examination
Gold Medal in ENT University Examination
Distinction in Anatomy University Examination
Distinction Poster at ATC Boston May 2009

Paper Presentations

European Vasculitis Society Meeting Early Disease Response as Predictors of Long Term Outcomes in ANCA Associated Vasculitis - 2017
ALEmtuzumab for Relapsing and Refractory Primary Systemic Vasculitis – A Trial of Efficacy and Safety (ALEVIATE): A Randomised Open Label Phase II Clinical Trial, Vasculitis conference, Philadelphia, 2019
Peripheral T helper cells may play a role in the pathogenesis of ANCA associated vasculitis, Renal Association Oct 14th, 2020
Wagner J , Harrison E. M , Martinez M , Pero D , Blane B , Mayer G , Leierer J , Gopaluni S , Holmes M A , Parkhill J , Peacock S J , Jayne D R , Kronbichler A ( 2019 ). The Composition and Functional Protein Subsystems of The Human Nasal Microbiome in Granulomatosis with Polyangiitis ? : A Pilot Study. Microbiome ( 2019 ) 7 : 137 https://doi.org/10.1186/s40168-019-0753-z
Evaluation of PR3 - ANCA Status After Rituximab for ANCA -Associated Vasculitis. McClure ME , Wason J , Gopaluni S , Tieu J , Smith RM , Jayne DR , Jones RB. J Clin Rheumatol. 2019 Mar 20. doi: 10.1097/RHU.0000000000001030
A Novel Glucocorticoid - Free Maintenance Regimen for Anti-Neutrophil Cytoplasm Antibody - Associated Vasculitis. Pepper RJ , McAdoo SP , Moran SM , Kelly D , Scott J , Hamour S , Burns A , Griffith M , Galliford J , Levy JB , Cairns TD , Gopaluni S , Jones RB , Jayne D , Little MA , Pusey CD , Salama AD. Rheumatology ( Oxford ). 2019 Feb 1 ; 58 ( 2 ) : 260 - 268. doi: 10.1093/rheumatology/key288.
Effect of Disease Activity at Three and Six Months After Diagnosis on Long - Term Outcomes in Antineutrophil Cytoplasmic Antibody - Associated Vasculitis. Gopaluni S , Flossmann O , Little MA , O’Hara P , Bekker P , Jayne D ; European Vasculitis Society. Arthritis Rheumatol. 2019 May ; 71 ( 5 ) : 784 - 791. doi: 10.1002/art.40776. Epub 2019 Mar 28.
B Cell Therapy in ANCA - Associated Vasculitis : Current and Emerging Treatment Options. McClure M , Gopaluni S , Jayne D , Jones R. Nat Rev Rheumatol. 2018 Oct ; 14 ( 10 ) : 580 - 591. doi: 10.1038/s41584-018-0065-x. Epub 2018 Aug 14. Review.
A Retrospective Study Comparing The Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts. Karadag O , Erden A , Bilginer Y , Gopaluni S , Sari A , Armagan B , Ertenli I , Ozen S , Jayne D. Rheumatol Int. 2018 Oct ; 38 ( 10 ) : 1833 - 1840. doi: 10.1007/s00296-018-4122-1. Epub 2018 Aug 11.
Trimethoprim - Sulfamethoxazole Prophylaxis Prevents Severe / Life - Threatening Infections following Rituximab in Antineutrophil Cytoplasm Antibody - Associated Vasculitis. Kronbichler A , Kerschbaum J , Gopaluni S , Tieu J , Alberici F , Jones RB , Smith RM , Jayne DRW. Ann Rheum Dis. 2018 Oct ; 77 ( 10 ) : 1440 - 1447. doi: 10.1136/annrheumdis2017-212861. Epub 2018 Jun 27.
McAdoo , S. P. , Medjeral - Thomas , N. , Gopaluni , S. , Tanna , A. , Mansfield , N. , Galliford , J. , Griffith , M. , et al. ( 2018 ). Long - Term Follow - Up of A Combined Rituximab and Cyclophosphamide Regimen in Renal Anti - Neutrophil Cytoplasm Antibody - Associated Vasculitis. Nephrology , Dialysis , Transplantation : Official Publication of The European Dialysis and Transplant Association – European Renal Association , 2018 , 33 ( 5 ) , 899. https://doi.org/10.1093/ndt/gfy075
Gopaluni , S. , Smith , R. M. , Lewin , M. , McAlear , C. A. , Mynard , K. , Jones , R. B. , Jayne , D. R. W. ( 2017 ). Rituximab Versus Azathioprine as Therapy for Maintenance of Remission for Anti - Neutrophil Cytoplasm Antibody -Associated Vasculitis ( RITAZAREM ) : Study Protocol for a Randomized Controlled Trial. Trials , 18 ( 1 ) , 112. http://doi.org/10.1186/s13063-017-1857-z
Gopaluni , S. , Sherif , M. , & Ahmadouk , N. A. 2016. Cochrane Systematic Review : Interventions for Chronic Kidney Disease - Associated Restless Legs Syndrome. Cochrane Database of Systematic Reviews. doi: 10.1002/ 14651858. CD010690.pub2
Gopaluni , S. , & Jayne , D. ( 2016 ). Clinical Trials in Vasculitis. Current Treatment Options in Rheumatology , 2(2) , 161–177. doi:10.1007/s40674-016-0045-8
Gopaluni , S. and Jayne , D. 2015. Immune Vasculitis. eLS. 1– 8. DOI: 10.1002/9780470015902.a0002150.pub3
Hindocha , S. , Gopaluni , S. , Collins , G. P. , & Shenbagaraman , P. ( 2015 ). Focal Segmental Glomerulosclerosis in A Patient with Mantle Cell Lymphoma. BMJ Case Reports , 2015. doi:10.1136/bcr-2015-211765
Gopaluni , S. , Gibson , M. , & Mohteshamzadeh , M. ( 2014 ). An Unusual Case of Familial Cystic Kidney Disease. Clinical Kidney Journal , 7 ( 5 ) , 484 – 485. doi:10.1093/ckj/sfu075
Gopaluni , S. , Sherif , M. , & Ahmadouk , N. A. ( 2013 ). Protocol - Interventions for Chronic Kidney Disease -Associated Restless Legs Syndrome. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD010690.
Ball MJ , Gopaluni S , Mathavakkannan S , Brian M , and Farrington K. An Immunocompromised Dialysis Patient with Skin and Bone Lesions. NDT Plus 2010 0: sfq010v1-sfq010; doi:10.1093/ndtplus/sfq010
S Gopaluni , S Lines , AJP Lewington , Acute Kidney Injury in The Critically ill Patient , Current Anaesthesia & Critical Care 21 ( 2 ) , 60 - 64 , April 2010
Seerapani Gopaluni , Aadil Shaukat , Martin Gray , Roshni Gokhale and M Al - Bustami Premature Myocardial Infarction Presenting with Acuacutete Pulmonary Embolism : A Case Report. Journal of Medical Case Reports 2009 , 3 : 8786